Adial Pharmaceuticals (ADIL) Research & Development (2017 - 2026)
Adial Pharmaceuticals (ADIL) posted Research & Development of $440,000 for Q2 2026, down 39.9% from $732,000 a year earlier but up 1.7% from the prior quarter.
Powered by 
Analysis
Adial Pharmaceuticals (ADIL) Research & Development (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Adial Pharmaceuticals was $2.01 million, down 37.9% year-over-year; for FY2025, it was $2.62 million, down 18.9% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of -14.9% (FY2020 to FY2025).
- In prior years, Adial Pharmaceuticals' Research & Development was $3.23 million in FY2024 (+154.9%), $1.27 million in FY2023 (-35.0%), $1.95 million in FY2022 (-76.8%) and $8.4 million in FY2021 (+43.4%).
- Quarterly Research & Development has run from a low of $207,128 in Q3 2023 to a high of $2.33 million in Q4 2021 over five years.
- On a year-over-year basis, Research & Development has declined in each of the last five quarters, with growth averaging 58.1% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q3 2024, with growth of 398.1%; the weakest was Q4 2022, with a decline of 77.2%.
- According to Business Quant data, Research & Development for the three prior quarters was $432,530 (Q1 2026), $619,396 (Q4 2025) and $521,069 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Adial Pharmaceuticals | 18.67 Mn | 18.67 Mn | - | 440,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 440,000.00 |
| Mar 31, 2026 | 432,530.00 |
| Dec 31, 2025 | 619,396.00 |
| Sep 30, 2025 | 521,069.00 |
| Jun 30, 2025 | 732,000.00 |
| Mar 31, 2025 | 746,891.00 |
| Dec 31, 2024 | 730,793.00 |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 1.01 Mn |
| Mar 31, 2024 | 454,278.00 |
| Dec 31, 2023 | 264,437.00 |
| Sep 30, 2023 | 207,128.00 |
| Jun 30, 2023 | 429,896.00 |
| Mar 31, 2023 | 365,616.00 |
| Dec 31, 2022 | 531,841.00 |
| Sep 30, 2022 | 696,073.00 |
| Jun 30, 2022 | 679,966.00 |
| Mar 31, 2022 | 596,341.00 |
| Dec 31, 2021 | 2.33 Mn |
| Sep 30, 2021 | 1.69 Mn |
API Access
Adial Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ADIL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ADIL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ADIL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();